News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Volta Medical conclut un accord de développement conjoint avec GE HealthCare afin d’améliorer les procédures d’arythmies grâce à des technologies d’électrophysiologie basées sur l’IA
Volta Medical et GE HealthCare concluent un accord pour améliorer les procédures d'arythmies avec des technologies d'électrophysiologie basées sur l'IA -
COMMUNIQUÉ DE PRESSE
Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies
Volta Medical partners with GE HealthCare to enhance arrhythmia procedures using AI-driven electrophysiology technologies. Collaboration focuses on improving patient outcomes for atrial fibrillation -
COMMUNIQUÉ DE PRESSE
1606 Corp. Announces Austen Lambrecht as CEO and Chairman of the Board
1606 Corp. appoints Austen Lambrecht as new CEO, driving stock price and volume growth. Lambrecht's extensive experience in public companies and AI technology positions him well to lead 1606's strategic initiatives -
COMMUNIQUÉ DE PRESSE
Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer
Jaguar Health, Inc. announces initial results from Phase 3 OnTarget trial of crofelemer for cancer patients' diarrhea prophylaxis. Positive signals for breast and respiratory cancer subgroups in multicenter, double-blind study -
